000 01342 a2200385 4500
005 20250512214632.0
264 0 _c19820722
008 198207s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1982.94
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerenbaum, M C
245 0 0 _aIn vivo biological activity of the components of haematoporphyrin derivative.
_h[electronic resource]
260 _bBritish journal of cancer
_cApr 1982
300 _a571-81 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xmetabolism
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aHematoporphyrin Derivative
650 0 4 _aHematoporphyrins
_xmetabolism
650 0 4 _aHydrolysis
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aNecrosis
650 0 4 _aNeoplasms, Experimental
_xdrug therapy
650 0 4 _aPhotochemotherapy
650 0 4 _aRadiation-Sensitizing Agents
_xmetabolism
650 0 4 _aTime Factors
700 1 _aBonnett, R
700 1 _aScourides, P A
773 0 _tBritish journal of cancer
_gvol. 45
_gno. 4
_gp. 571-81
856 4 0 _uhttps://doi.org/10.1038/bjc.1982.94
_zAvailable from publisher's website
999 _c6462044
_d6462044